Advertise on podcast: Bioprocess With The Bozenhardts

How will the bioprocessing facility of the future adapt to meet the therapeutic needs of the day, and well into the future? What evolutionary steps should you be taking today to meet those needs? On this episode of Bioprocess With The Bozenhardts, Herman and Erich Bozenhardt, P.E. are queried by host Louise Hall, PMP as they enter their time machine and hit fast-forward to envision the facilities you'll need to accommodate the future of biologic medicine demand.

Join Herman & Erich Bozenhardt, PE as they revisit the evolution of biopharma plant engineering in a deep discussion with host Louise Hall, PMP. The Bozenhardts and Hall reflect on how far we've come, and why the lessons we've learned along the journey are so important to charting the course ahead. From aseptic processing to HVAC considerations, the trio leaves no stone unturned in this lively retrospective.

Herman & Erich Bozenhardt, PE are back, joining Louise Hall, PMP for a discussion on equipping your bioprocessing facilities to safely and efficiently handle the potent compounds, solvents, and peroxides used in the production of biologics. The trio discuss the adaptation of technologies and procedures to mitigate risk in the process of manufacturing exosomes, antibody drug conjugates, viral vectors, and more. 

Are you in the process of planning a new biotech facility? Acquiring an existing facility? Transferring technology to an outsourced partner? Don't miss out on the collective wisdom shared by Louise Hall, PMP, Erich Bozenhardt, PE, and longtime bioprocessing facilities consultant Herman Bozenhardt on this episode of Bioprocess With The Bozenhardts. The trio discusses how to ensure a successful business outcome and check all of your regulatory boxes.

How close are we to taking a tablet and growing a new kidney? Bonus points if you caught the Star Trek reference. On this episode of Bioprocess With The Bozenhardts, Louise Hall, PMP discusses advances in human tissue-based therapies with Erich Bozenhardt, PE and Herman Bozenhardt. Join the conversation for an update on advances to the systems and processes biopharmaceutical companies are using to restore and regenerate disease-affected human tissues.

Join Louise Hall, PMP as she queries Herman and Erich Bozenhardt, PE on the resurgence of liposomes in the wake of their role in COVID-19 vaccine and therapeutic development. The trio discuss how the technology has evolved, what we've learned, and what the future holds for the role of liposomes in biotherapeutic development moving forward.

Join biopharma facilities and tech transfer expert Louise Hall, PMP, veteran consultant Herman Bozenhardt, and Erich Bozenhardt, PE for a conversation on the considerations biopharma executives need to ponder before jumping into a contract manufacturing relationship. From cultural match to GMP qualifications to regulatory experience, the Bozenhardts go deep on the keys to making the right choice.

On this episode of Bioprocess With The Bozenhardts, Erich and Herman share insight into the shortage of manufacturing space for up-and-coming cell & gene therapies, and the factors you'll need to consider—from location to physical infrastructure to utilities—as you plan your biomanufacturing facilities build-out.

Bioprocess With The Bozenhardts is back, with a fresh episode packed with advice from Herman and Erich on the selection of filling systems for biopharmas. Listen in as the Bozenhardts give us an update on the process, logistics, and administration trends that are informing filling system decisions today, and offer direction on making choices that will prepare you for the fast-advancing therapies of tomorrow.

Listen to Herman and Erich define Biopharma 4.0 and discuss how machine learning and artificial intelligence are shaping drug discovery, development, processing, and manufacturing. On this episode of Bioprocess With The Bozenhardts, you'll learn how new technologies will impact your next facility and what elements of Biopharma 4.0 you can put to work for you today.  

Liposomes have benefits, but their production complexity, “shell” deterioration, and particle size variability and distribution make them a production nightmare that is often more of an art than a science. On this episode, Herman and Erich uncover the resurrection of the liposome and offer guidance on its use. 

What impact will personalized medicine have on the way you develop, produce, and deliver biologics to patients? What changes should you be making today to accommodate the therapies you'll be manufacturing tomorrow? Today's episode of Bioprocess With The Bozenhardts shift gears into patient centricity, the personalized medicine cliff, and how these trends will affect the bioprocessing facilities of the future.